ClinicalTrials.govpublic full text
Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
hyperlipidemia, mixed hyperlipidemia, dyslipidemia, niacin, hydroxymethylglutaryl-coa reductase inhibitors, combination lipid therapy, lovastatin, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010778
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.